However, a human disease called osteoglophonic dysplasia caused by activating mutations in FGFR1 is often associated with hypophosphatemia due to increased FGF23 levels (60), which also suggests the regulation of FGF23 production by FGFR signaling. This evidence concerns the gene FGFR1 and hypophosphatemia.